Blood & Marrow Transplant (BMT) Program

The Blood & Marrow Transplant Program (BMT) at UI Health specializes in a variety of stem cell transplant procedures to provide the best possible outcomes in patients with cancers of the bone marrow, specific solid tumorous cancers, and non-neoplastic blood disorders.

A part of the Division of Hematology & Oncology, our program is nation nationally recognized for innovative research and quality care in the field of stem cell transplantation. Our program is designated as a Blue Distinction Center for Transplants® by Blue Cross and Blue Shield® for demonstrating outstanding quality, expertise and patient outcomes in Adult Blood & Marrow Stem Transplant.


Request An Appointment Phone Icon 312.413.1715

Blood Cancers & Diseases We Treat

Our dedicated team of doctors, nurses, physician assistants, and transplant coordinators are specially trained to deliver the best treatment for a number of cancers and diseases of the blood, including:

  • Amyloidosis
  • Aplastic Anemia
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Chronic Myeloid Leukemia
  • Chronic Lymphoblastic Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Myelodysplastic Syndromes
  • Sickle Cell Disease
  • Germ Cell Tumors

Stem Cell Transplant Treatments

The BMT Program at UI Health provides a number of stem cell transplant procedures to deliver the best possible outcomes in patients with cancers and diseases of the blood. BMT treatments include:

  • Autologous stem cell transplant: Stem cell transplant that uses a patient's own stem cells for transplantation.
  • Allogeneic stem cell transplant: This procedure uses stem cells from a matched related or unrelated donor for transplantation.
  • Haploidentical stem cell transplant: Transplant with stem cells from a half-matched related donor.
  • Umbilical cord stem cell transplant: This stem cell procedures uses partially matched unrelated stem cells from the donor's umbilical cord.
  • CAR T-Cell Therapy: UI Health is an approved treatment site for CAR (Chimeric Antigen Receptor) T-Cell Therapy, an FDA-approved therapy for treating specific types of lymphoma and leukemia in patients who have not responded to previous cancer treatments.

Patients referred to the BMT Program are assisted by our pre-transplant nurse coordinators and discussed weekly at our multispecialty meetings. All of our BMT patients meet with our team of BMT physicians, pharmacists, nurse practitioners, nurses, social workers, in addition to physical therapists and dietitians dedicated to BMT patients.

Contact Us

Our Location

Outpatient Care Center (OCC), Suite 1E
1801 W. Taylor St.
Chicago, IL 60612


To contact the BMT Patient Coordinator Office, please call 312.413.1715. To contact the Division of Hematology & Oncology, please call 312.996.1581.